Mustang Bio Inc reports results for the quarter ended in December - Earnings Summary

Mustang Bio

29/03/2023 22:35

* Mustang Bio Inc  MBIO.OQ  reported a quarterly adjusted
loss
of 18 cents​​ per share for the quarter ended in December. The
mean expectation of four analysts for the quarter was for a loss
of 19 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Mustang Bio Inc's reported EPS for the quarter was a loss
of 18
cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Mustang Bio Inc shares had fallen by 8.4% this quarter.
    * The company reported a quarterly loss of $19.63 million.
    * Wall Street's median 12-month price target for Mustang Bio
Inc
is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 29 at 09:35 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.19          -0.18          Beat
 Sep. 30 2022      -0.20          -0.18          Beat
 Jun. 30 2022      -0.21          -0.19          Beat
 Mar. 31 2022      -0.18          -0.20          Missed